-
Most Popular
Search Results
240 results for fsa
Will This FDA Approval Affect Amgen Stock Significantly?
AMGN stock is still riding on a rocky road despite news of a new FDA approval. Here’s what Amgen investors need to know.
FDA Proposes Graphic Cigarette Warning Labels
The U.S. Food & Drug Administration (FDA) is proposing a new rule that requires the use of graphic cigarette warning labels.
Tesla’s Public FSD Beta Is A Huge Mistake
Tesla is risking its reputation and brand value by having customers beta test its driverless software. Tesla stock could take a hit.
Palantir Stock Surges on FDA Contract Victory
PLTR stock is surging even higher after Palantir just landed a three-year contract with the U.S. Food and Drug Administration.
Trade of the Day: Goldcorp Inc. (USA) (GG)
Geopolitics will likely drive commodity prices higher in the short term. The U.S. dollar has been on a tremendous rally for a while now, but…
Imax Corp (USA) Is the Tesla of the Movie Business
IMAX stock is perpetual no-growth story trading at 273x earnings.
FDA Issues Black Licorice Overdose Warning
The U.S. Food and Drug Administration (FDA) is warning U.S. consumers to limit their intake of black licorice as Halloween approaches.
PSA Priced to Perfection in a Highly Competitive Industry
PSA is a well-run and financially strong company that will see increased earnings into 2015, but those expectations are already priced in.
FDA Approves 41 New Drugs in 2014
The FDA has approved 41 new drugs in 2014–the highest tally since 1996. The list includes 15 drugs for rare diseases.
FDA Issues Warning on Hepatitis C Drugs
The Food and Drug Administration (FDA) has issued a warning surrounding several Hepatitis C drugs such as Sovaldi, Harvoni and Gilead Sciences.
FDA Approves Ecstasy Trials for PTSD Sufferers
The Food and Drug Administration (FDA) has approved clinical trials for ecstasy to treat PTSD sufferers, including police and firefighters.
Bear of the Day: Agrium Inc. (USA) (AGU)
Agrium (AGU) stock is in trouble, especially when you consider the fertilizer industry’s long-lasting struggles and gloomy outlook.
USA TODAY Gets a Facelift at Age 30
Gannett’s flagship newspaper USA TODAY — America’s second-largest daily print publication — will sport a new redesign for its 30th birthday.
FDA, Insurers Demand Tests for New Drugs
Pressure on pharmaceutical companies for evidence that their drugs work is fueling a surge in the global market for “companion diagnostics.”
Gannett’s USA Today Resumes Deal with Starbucks
As of this week, Starbucks (SBUX) has started offering copies of USA Today to its java-drinking customers. The flagship paper of media giant Gannett (GCI),…
Ranbaxy Closes In on FDA Approval for Generic Lipitor
Ranbaxy could sell $650 million worth of the drug in its first 180 days. But Pfizer is battling hard to keep branded Lipitor alive.
FSR Stock Could Be the Top Short Squeeze Stock Now
Fisker is in focus as the short interest in FSR stock (and the entire market) continue to attract investors’ attention.
GILD Stock: FDA Greenlights Gilead Sciences, Inc. Hep-C Drug Epclusa
Gilead Sciences (GILD) stock is up big Tuesday after the FDA granted its drug, Epclusa, approval for use in chronic HCV patients.
3 BDCs to Buy for Their Big, Fat Yields
Middle-market companies need to grow, and that’s what fuels BDCs’ high-single-digit and even double-digit yields to shareholders.
Bluebird Bio (BLUE) Stock Is in Focus Following FDA Approval
The Boston-based biotech company has secured FDA approval for one of its gene therapies. Let’s take a closer look at BLUE stock.
Fisker Shares Could Begin Moving Higher as Production Ramps Next Year
Fisker stock could begin moving higher as production ramps next year. FSR stock could rise 27% next year as the company approaches production, especially now…
Novavax Stock Is in Prime Position For Speculation
NVAX stock is on the cusp of the FDA approval that has long eluded the firm, meaning now is the best time to speculate on…
Ocugen Stock Is A Bust After Covaxin’s Emergency Use Rejection
OCGN stock is of no value to investors now that federal regulators closed the door on its Covid-19 vaccine commercialization efforts.
FSR Stock Pops as One Analyst Chooses Fisker Over Tesla
Today, a big analyst upgrade for Fisker has sent shares of FSR stock materially higher at the time of writing as speculators jump in.
10 – 10 of 240 results
